Sleep Apnea and Eng3 Technology
July 7th, 2008Sleep Apnea (or Sleep Apnoea), a condition where people stop breathing for periods of 10 seconds or longer while sleeping, affects up to 18 million people in the US. Interference in breathing reduces the amount of oxygen in the blood. Eventually this lack of oxygen triggers the lungs to suck in air, causing gasping or snorting, and for the person to move to a lighter stage of sleep, or sometimes to wake up.
Sleep apnea is associated with serious heart and circulatory problems including hypertension (high blood pressure) and heart disease, as well as asthma, diabetes, kidney failure, peripheral nerve damage, seizures, epilepsy, and other nerve disorders.
Adults suffering from sleep apnea may experience excessive daytime sleepiness, headaches, irritability, reduced concentration and impaired mental/emotional functioning. Essentially they are not getting deep, restful sleep and enough oxygen at night, which has significant effect on mental and emotional wellbeing, and health.
People who suffer from sleep apnea use Eng3′s device for several reasons:
1) At the cellular level, Eng3 technology is improving cell metabolism so cells utilize oxygen better. When using Eng3 technology, those who suffer from sleep apnea will be using oxygen better both while awake and while sleeping.
2) Improved cell metabolism and oxygen utilization contributes to improved concentration during the day and better sleep at night.
You may be interested in a study on Sleep Apnea done with our technology by Marion Burmann-Urbanek, M.D., and Hendrik Straube, M.D. Activated Air Therapy is Tested.